lozapine 100 mg
taro international ltd, israel - clozapine - tablets - clozapine 100 mg - clozapine - clozapine - treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics.reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state.suicidal behavior refers to actions by a patient that put him/herself at risk for death
clozapine tablet 25 mg
pharmline marketing pte. ltd. - clozapine - tablet - 25 mg - clozapine 25 mg
clozapine tablet 100 mg
pharmline marketing pte. ltd. - clozapine - tablet - 100 mg - clozapine 100 mg
clozapin 25 - 1a pharma tablets 25mg
1 a pharma gmbh - clozapine 25 mg - tablet
clozapin 100 - 1a pharma
1 a pharma gmbh - clozapine 100 mg - tablet
clozaril- clozapine tablet
tya pharmaceuticals - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 25 mg - clozaril is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the significant risk of agranulocytosis and seizure associated with its use, clozaril should be used only in patients who have failed to respond adequately to standard antipsychotic treatment . [see warnings and precautions (5.1, 5.4)] the effectiveness of clozaril in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozaril and chlorpromazine in patients who had failed other antipsychotics . [see clinical studies (14.1)] clozaril is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to action
fazaclo- clozapine tablet, orally disintegrating
jazz pharmaceuticals, inc. - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 12.5 mg - fazaclo is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with its use, fazaclo should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5) ]. the effectiveness of clozapine in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozapine and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1)]. fazaclo is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for death. the effectiveness o
clozaril- clozapine tablet
hls therapeutics (usa), inc. - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 25 mg - clozaril is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with its use, clozaril should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5)] . the effectiveness of clozaril in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozaril and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1)] . clozaril is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for death. the effectiveness of c
versacloz- clozapine suspension
jazz pharmaceuticals, inc. - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 50 mg in 1 ml - versacloz is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with its use, versacloz should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5) ] . the effectiveness of clozapine in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozapine and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1)] . versacloz is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for death. the effectivene
clozapine 100mg/5ml oral solution
special order - clozapine - oral solution - 20mg/1ml